Maja Lieven (née Rennig)

Maja Lieven (née Rennig) has a diverse work experience spanning various roles and companies. Maja is currently the Team Lead Production at LenioBio GmbH since September 2021. Prior to that, they were the Co-Founder and Chief Technology Officer at Mycropt, a start-up company they co-founded in September 2018. Maja held the CTO position until August 2021.

From 2014 to 2021, Maja worked at The Novo Nordisk Foundation Center for Biosustainability. Maja started as a Postdoctoral Researcher, conducting research projects in synthetic biology tool development and production of lytic polysaccharide monooxygenases (LPMOs). Maja also went on maternity leave from April 2020 to January 2021. Maja then resumed their role as a Postdoctoral Researcher until June 2020. Maja has a PhD in synthetic biology from Goethe-Universität Frankfurt a. Main, where they conducted and supervised research projects focused on optimizing protein production in bacterial cell factories.

Maja also has experience as a Research Consultant at CloneOpt in July and August 2018, and as an Industrial Partnership at Tailorzyme Aps from June 2016 to June 2017. Maja started their research career as a Student Research Assistant and Research Intern at Goethe-Universität Frankfurt a. Main from 2012 to 2013. Maja also worked as a Student Research Assistant and Research Intern at Paul-Ehrlich-Institut in August 2012.

Overall, Maja has a strong background in synthetic biology, research, and leadership roles.

Maja Lieven (née Rennig) pursued their education in a chronological order. Starting in 2009, they attended Goethe University Frankfurt, where they obtained a Diploma in Biochemistry in 2014. Following this, they proceeded to DTU - Technical University of Denmark, where they pursued a Doctor of Philosophy (PhD) degree. Their doctoral studies were completed between 2014 and 2017, although the specific field of study is not provided.